1. Home
  2. FIGS vs HROW Comparison

FIGS vs HROW Comparison

Compare FIGS & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FIGS Inc.

FIGS

FIGS Inc.

HOLD

Current Price

$13.43

Market Cap

2.1B

ML Signal

HOLD

HROW

Harrow Inc.

HOLD

Current Price

$33.15

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIGS
HROW
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
FIGS
HROW
Price
$13.43
$33.15
Analyst Decision
Hold
Strong Buy
Analyst Count
7
8
Target Price
$15.93
★ $69.86
AVG Volume (30 Days)
★ 2.3M
487.9K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 850.00
71.43
EPS
★ 0.18
N/A
Revenue
★ $419,591,000.00
N/A
Revenue This Year
$14.09
$31.62
Revenue Next Year
$7.72
$50.77
P/E Ratio
$69.39
★ N/A
Revenue Growth
★ 59.47
N/A
52 Week Low
$6.58
$28.54
52 Week High
$17.48
$54.98

Technical Indicators

Market Signals
Indicator
FIGS
HROW
Relative Strength Index (RSI) 49.27 35.19
Support Level $12.88 $32.46
Resistance Level $15.94 $36.37
Average True Range (ATR) 0.67 1.33
MACD -0.17 -0.10
Stochastic Oscillator 59.07 20.66

Price Performance

Historical Comparison
FIGS
HROW

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: